Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
509.00    0.00 (0.00%)
Bid:
511.00
Ask:
512.00
Spread: 1.00 (0.196%)
Market Cap: £499.86m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Trading Statement

11 Jul 2017 07:00

RNS Number : 6476K
Galliford Try PLC
11 July 2017
 

 

 

GALLIFORD TRY PLC

 

TRADING UPDATE

11 JULY 2017

 

Galliford Try plc, the housebuilding, regeneration and construction group, today provides the following update on trading for the year ended 30 June 2017. All figures are as at 30 June 2017, unless otherwise stated, and all comparatives relate to the prior year equivalent period. The Group expects to announce its results for the full year on 13 September 2017.

 

Overview

 

· A strong underlying financial and operating performance across all three businesses for FY 2017, with profits towards the upper end of the analysts' range 1

· Linden Homes and Partnerships & Regeneration expected to deliver increased revenue and improved operating margins, while newer contracts in Construction are performing well

· No movement in the £98m non-recurring costs in Construction, as announced on 3 May 2017

· Modest net cash at 30 June 2017 (2016: net debt £9m)

· Expect to pay dividend in line with previous guidance

· Well positioned to deliver against 2021 strategic targets

 

Linden Homes

 

Linden Homes is expected to report a strong performance for the full year. Revenue growth has accelerated in the second half, driven by solid growth in volumes, with total completions (including units in joint ventures) up 7% to 3,296 units (2,876 units net of our partners' shares) at 30 June 2017 (2016: 3,078 and 2,691 units respectively). Average sales rates in the second half were strong at 0.68 units per site per week, up from 0.56 in H1 2017, from a reduced average number of outlets for the full year of 77 (2016: 80). The average private sales price was up 6% to £354,000 (2016: £335,000). Reflecting the strategy to increase product standardisation and improve operating efficiencies, the operating margin has continued to improve.

 

The business maintains a strong forward order book to start the next financial year, with sales carried forward of £373m at 30 June 2017 (2016: £380m). All land plots have been secured for FY 2018, with 83% of plots secured for FY 2019. The landbank stands at 10,650 plots, having decreased from 11,500 plots in FY 2016 in line with our strategy to hold a shorter landbank, equivalent to 3.5 years. Also in line with our stated plan, we have successfully increased our strategic land assets.

 

Partnerships & Regeneration

 

Performance in Partnerships & Regeneration continues to improve, with both revenue and margin increased over FY 2016 helped by growth in higher-margin mixed-tenure projects. The business is making good progress against its strategy, supported by the recent acquisition of the mixed-tenure developer, Drew Smith, in Hampshire, which is expected to accelerate growth across the southern region. At 30 June 2017, the contracting order book is up 23.5% at £1.05bn (2016: £0.85bn) and the landbank is 2,700 plots (2016: 2,700).

 

Construction

 

The underlying portfolio of newer contracts continues to perform well. As announced on 3 May 2017, Construction's reported performance in FY 2017 will be impacted by £98m non-recurring costs following a reappraisal of costs to complete and recoveries, principally from two large legacy contracts. These also affected the business's cash position, which decreased to £136m at 30 June 2017, from £160m in 2016. As outlined previously the business no longer undertakes these types of fixed-price contracts on large infrastructure projects. Construction enters the new financial year with a high quality order book of £3.5bn (2016: £3.5bn), predominantly in the public and regulated sectors, which includes 84% of projected revenue for FY 2018 (2016: 82%).

 

Financial Position

 

We will report net cash at 30 June 2017 of less than £10m (2016: net debt of £9m) and average net debt over the full year is expected to be lower than previous guidance at below £250m. While the non-recurring costs in Construction have impacted the Group's cash position, overall Galliford Try maintains a strong balance sheet, with the debt private placement and facility extension in FY 2017 providing diversification and flexibility in the Group's funding sources.

 

Outlook

 

The Group's outlook for FY 2018 is unchanged. Linden Homes is expected to deliver further volume growth and improvement in the operating margin. Partnerships & Regeneration continues to enhance its position to benefit from the demand for affordable housing, while Construction's margin is expected to increase as we close out legacy positions.

 

Peter Truscott, Chief Executive, commented:

 

"Galliford Try made excellent operating progress in the financial year, with our reorganised management teams focused on improving operating efficiency across the Group, and driving revenue growth in Linden Homes and Partnerships. Reflecting this operational focus and benefiting from robust market conditions over the last twelve months, we expect to deliver a strong underlying result for FY 2017 notwithstanding the impact on the Group's reported financial performance from the non-recurring costs in our Construction business, as previously announced.

 

 

 

As we enter the new financial year, we are cautious about the impact of the current political uncertainty following the general election and the medium-term outlook for the macro economy. However, all three businesses have clearly defined plans to improve operating efficiency and grow revenue and margins, providing the Group with confidence in its ability to deliver a strong performance even in a period of lower growth in the wider economy. We enter the financial year with a Group order book of £4.9bn, giving us a solid foundation to deliver growth in FY 2018. Overall, we remain well positioned to deliver against our medium-term targets for 60% growth in profit before tax to FY 2021, a five year CAGR on dividend of at least 5% and a return on net assets in FY 2021 of at least 25%, while rebuilding dividend cover to 2.0x.

 

Reflecting a strong underlying performance, the strength of our balance sheet and our confidence in the prospects for each of our businesses, we expect to pay a final dividend in line with previous guidance."

 

 

Conference Call

 

A conference call for Analysts and Investors will be held at 08:30am (UK time)

Participant telephone number: +44 (0)20 3139 4830

Participant passcode:  17524923#

 

For further enquiries:

 

Galliford Try Peter Truscott, Chief Executive 01895 855001

Graham Prothero, Finance Director

 

Tulchan Communications James Macey White / Martin Pengelley 020 7353 4200

 

Notes to Editors

 

Galliford Try plc is a leading UK housebuilding, regeneration and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2016, the Group generated revenue of £2.7 billion.

 

1 The range of analysts' forecasts for profit before tax for the year ending 30 June 2017 is £46m to £59m based on forecasts at 1 July 2017.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVRDEIILID
Date   Source Headline
6th Jul 20233:30 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSTransaction in Own Shares
4th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20232:32 pmRNSTotal Voting Rights
21st Jun 20237:00 amRNSTransaction in Own Shares
9th Jun 20237:00 amRNSTransaction in Own Shares
8th Jun 20237:00 amRNSSettlement Agreed and Special Dividend
7th Jun 20237:00 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
1st Jun 202311:00 amRNSConfirmation of Directorate Change
1st Jun 202310:15 amRNSTotal Voting Rights
1st Jun 20237:00 amRNSTransaction in Own Shares
31st May 20237:00 amRNSTransaction in Own Shares
18th May 20233:30 pmRNSHolding(s) in Company
18th May 20237:00 amRNSTransaction in Own Shares
17th May 20233:00 pmRNSAppointment of Non Executive Director
17th May 20237:00 amRNSTransaction in Own Shares
11th May 20237:10 amRNSContract
10th May 20237:00 amRNSTransaction in Own Shares
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 202311:00 amRNSTotal Voting Rights
2nd May 20237:10 amRNSContract
2nd May 20237:00 amRNSTransaction in Own Shares
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20232:00 pmRNSDirector/PDMR Shareholding
13th Apr 20237:10 amRNSContract
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 202310:00 amRNSTotal Voting Rights
31st Mar 20233:00 pmRNSConfirmation of Director Change
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:05 amRNSContract
29th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 20237:00 amRNSTransaction in Own Shares
24th Mar 20239:37 amRNSCorrection: Transaction in Own Shares
24th Mar 20237:00 amRNSContract
23rd Mar 20237:00 amRNSContract
22nd Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 202310:30 amRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSContract
8th Mar 20237:10 amRNSTransaction in Own Shares
8th Mar 20237:00 amRNSHalf-year Report
7th Mar 20237:00 amRNSTransaction in Own Shares
6th Mar 20237:00 amRNSContract
1st Mar 20239:35 amRNSTotal Voting Rights
27th Feb 20234:00 pmRNSHolding(s) in Company
24th Feb 202310:42 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.